Back to Search
Start Over
UK: Elan requests new MS approval NEWS DIGEST
- Source :
- The Financial Times. Sept 27, 2005, 26
- Publication Year :
- 2005
-
Abstract
- Elan Corporation and Biogen Idec yesterday moved to resuscitate their withdrawn multiple sclerosis drug Tysabri, as the two drugmakers submitted safety reviews to US regulators asking for approval to sell [...]
Details
- Language :
- English
- ISSN :
- 03071766
- Database :
- Gale General OneFile
- Journal :
- The Financial Times
- Publication Type :
- News
- Accession number :
- edsgcl.136683814